islets of langerhans transplantation

Summary

Summary: The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.

Top Publications

  1. ncbi Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
    A M Shapiro
    Surgical Medical Research Institute and the Department of Surgery, University of Alberta, Edmonton, Canada
    N Engl J Med 343:230-8. 2000
  2. ncbi Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets
    N Lumelsky
    Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-4092, USA
    Science 292:1389-94. 2001
  3. ncbi Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model
    Torsten Eich
    Department of Radiology, Oncology and Clinical Immunology, Division of Clinical Immunology, University Hospital, Uppsala, Sweden
    Transplantation 84:893-8. 2007
  4. ncbi Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes
    Bernhard J Hering
    Diabetes Institute for Immunology and Transplantation and Department of Surgery, University of Minnesota, Minneapolis 55455, USA
    JAMA 293:830-5. 2005
  5. ncbi International trial of the Edmonton protocol for islet transplantation
    A M James Shapiro
    Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada
    N Engl J Med 355:1318-30. 2006
  6. ncbi The role of the innate immunity in islet transplantation
    Lisa Moberg
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Sweden
    Ups J Med Sci 110:17-55. 2005
  7. ncbi Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation
    Sanja Cabric
    Division of Clinical Immunology, Department of Oncology, Radiology, and Clinical Immunology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Diabetes 56:2008-15. 2007
  8. ncbi Sustained reversal of diabetes following islet transplantation to striated musculature in the rat
    Tormod Lund
    Surgical Clinic, Section for Transplantation, Rikshospitalet University Hospital, Oslo, Norway
    J Surg Res 160:145-54. 2010
  9. ncbi Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation
    Ida Rasmusson Duprez
    Uppsala University, Department of Oncology, Radiology and Clinical Immunology, Division of Clinical Immunology, The Rudbeck Laboratory, Uppsala, Sweden
    Ups J Med Sci 116:8-17. 2011
  10. ncbi Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture
    Christian Toso
    Clinical Islet Transplant Program, Department of Surgery, University of Alberta, Edmonton, AB, Canada
    Transpl Int 23:259-65. 2010

Detail Information

Publications272 found, 100 shown here

  1. ncbi Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
    A M Shapiro
    Surgical Medical Research Institute and the Department of Surgery, University of Alberta, Edmonton, Canada
    N Engl J Med 343:230-8. 2000
    ..Registry data on patients with type 1 diabetes mellitus who undergo pancreatic islet transplantation indicate that only 8 percent are free of the need for insulin therapy at one year...
  2. ncbi Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets
    N Lumelsky
    Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-4092, USA
    Science 292:1389-94. 2001
    ..When injected into diabetic mice, the insulin-producing cells undergo rapid vascularization and maintain a clustered, islet-like organization...
  3. ncbi Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model
    Torsten Eich
    Department of Radiology, Oncology and Clinical Immunology, Division of Clinical Immunology, University Hospital, Uppsala, Sweden
    Transplantation 84:893-8. 2007
    ..Therefore, the objective of the present study was to develop a technique for imaging survival of transplanted islets in the peritransplant and early posttransplant phase...
  4. ncbi Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes
    Bernhard J Hering
    Diabetes Institute for Immunology and Transplantation and Department of Surgery, University of Minnesota, Minneapolis 55455, USA
    JAMA 293:830-5. 2005
    ..However, for islet transplants to become a widespread clinical reality, diabetes reversal must be achieved with a single donor to reduce risks and costs and increase the availability of transplantation...
  5. ncbi International trial of the Edmonton protocol for islet transplantation
    A M James Shapiro
    Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada
    N Engl J Med 355:1318-30. 2006
    ..We conducted an international, multicenter trial to explore the feasibility and reproducibility of islet transplantation with the use of a single common protocol (the Edmonton protocol)...
  6. ncbi The role of the innate immunity in islet transplantation
    Lisa Moberg
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Sweden
    Ups J Med Sci 110:17-55. 2005
    ..These findings have provided new insight into the nature of the IBMIR and offer several new strategies to improve the outcome of clinical islet transplantation...
  7. ncbi Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation
    Sanja Cabric
    Division of Clinical Immunology, Department of Oncology, Radiology, and Clinical Immunology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Diabetes 56:2008-15. 2007
    ..To avoid systemic treatment, the aim of the present study was to render the islet graft blood biocompatible by applying a continuous heparin coating to the islet surface...
  8. ncbi Sustained reversal of diabetes following islet transplantation to striated musculature in the rat
    Tormod Lund
    Surgical Clinic, Section for Transplantation, Rikshospitalet University Hospital, Oslo, Norway
    J Surg Res 160:145-54. 2010
    ..In the present study, a technique for intramuscular islet transplantation was developed and compared with intraportal islet transplantation in a syngeneic rat model...
  9. ncbi Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation
    Ida Rasmusson Duprez
    Uppsala University, Department of Oncology, Radiology and Clinical Immunology, Division of Clinical Immunology, The Rudbeck Laboratory, Uppsala, Sweden
    Ups J Med Sci 116:8-17. 2011
    ..In this study, we investigated the capacity of human mesenchymal stem cells (MSCs) to adhere to human islets of Langerhans and their effects in immune modulation and during blood interactions in vitro...
  10. ncbi Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture
    Christian Toso
    Clinical Islet Transplant Program, Department of Surgery, University of Alberta, Edmonton, AB, Canada
    Transpl Int 23:259-65. 2010
    ..Overall, these data demonstrate the beneficial effect of liraglutide on cultured human islets, preserving islet mass. They support the design of clinical studies looking at the effect of liraglutide in clinical islet transplantation...
  11. ncbi Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation
    Lisa Ozmen
    Department of Radiology, Oncology and Clinical Immunology, Division of Clinical Immunology, The Rudbeck Laboratory, University Hospital, Uppsala, Sweden
    Diabetes 51:1779-84. 2002
    ..This protective effect indicates that thrombin plays a pivotal role in IBMIR and suggests that thrombin inhibition can improve the outcome of clinical islet transplantation...
  12. ncbi Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets
    Gustaf Christoffersson
    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Diabetes 59:2569-78. 2010
    ..The aim of the current study was to evaluate striated muscle as a potential angiogenic site for islet transplantation...
  13. ncbi Positron emission tomography in clinical islet transplantation
    O Eriksson
    Department of Radiology, Oncology and Clinical Immunology, Division of Radiology, University Hospital, Uppsala, Sweden
    Am J Transplant 9:2816-24. 2009
    ..The technique has potential to be used to assess approaches to enhance islet survival and engraftment in clinical transplantation...
  14. ncbi In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver
    M Shimoda
    Division of Cardiology, Department of Internal Medicine, Baylor University Medical Center, Baylor Heart and Vascular Institute, 621 North Hall St, Suite H030, Dallas, TX 75226, USA
    Diabetologia 53:1669-79. 2010
    ..Here we examined the effect of non-viral VEGF delivery using UTMD on transplanted islets in vivo...
  15. ncbi Low revascularization of human islets when experimentally transplanted into the liver
    Joey Lau
    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Transplantation 87:322-5. 2009
    ..Human islets transplanted intraportally into the liver become poorly revascularized. This could contribute to the loss of function in human islets transplanted into the liver over time...
  16. ncbi Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes
    M D Bellin
    Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
    Am J Transplant 8:2463-70. 2008
    ..Our results suggest this immunosuppressive protocol may allow long-term graft survival...
  17. ncbi Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice
    Juliet A Emamaullee
    Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    Diabetes 58:1302-11. 2009
    ..The effect of neutralizing anti-IL-17 and recombinant IL-25 on the development of diabetes in NOD mice, a model of spontaneous autoimmune diabetes, was investigated in this study...
  18. ncbi Islet transplantation for brittle type 1 diabetes: the UIC protocol
    A Gangemi
    Division of Transplantation Department of Surgery, University of Illinois at Chicago, Chicago, IL, USA
    Am J Transplant 8:1250-61. 2008
    ..1 to 5.8 +/- 0.3 after 1 Tx in Group 2). HYPO scores markedly decreased in both groups. Combined treatment of etanercept and exenatide improves islet graft function and facilitates achievement of insulin-independence with less islets...
  19. ncbi Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation
    Ulrika Johansson
    Department of Radiology, Oncology and Clinical Immunology, Division of Clinical Immunology, Uppsala University, Sweden
    Am J Transplant 5:2632-9. 2005
    ....
  20. ncbi Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation
    Lisa Moberg
    Department of Radiology, Oncology, and Clinical Immunology, Division of Clinical Immunology, The Rudbeck Laboratory, University Hospital, Uppsala, Sweden
    Transplantation 76:1285-8. 2003
    ..In this study, the authors investigated whether compounds previously shown to affect TF and macrophage chemoattractant protein (MCP)-1 expression in monocytes and endothelial cells have the same effect in human islet cells...
  21. ncbi Proliferation of sorted human and rat beta cells
    G Parnaud
    Department of Genetic Medicine and Development, University Medical Center, 1 rue Michel Servet, 1211, Geneva 4, Switzerland
    Diabetologia 51:91-100. 2008
    ..The aim of the study was to determine whether purified beta cells can replicate in vitro and whether this is enhanced by extracellular matrix (ECM) and growth factors...
  22. ncbi Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation
    L Moberg
    Department of Radiology, Oncology, and Clinical Immunology, Division of Clinical Immunology, Rudbeck Laboratory, Uppsala, Sweden
    Lancet 360:2039-45. 2002
    ....
  23. ncbi Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
    Niraj M Desai
    Department of Surgery, Washington University School of Medicine, St Louis, MO, USA
    Transplantation 76:1623-5. 2003
    ..0 to 3.12 for tacrolimus. Given the potential toxicity of these agents to islets, the findings in this study may have implications for designing the next generation of immunosuppressive protocols for islet transplantation...
  24. ncbi Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation
    Herman Blomeier
    Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Transplantation 82:452-9. 2006
    ..The scaffold may also be useful to deliver bioactive molecules to modify the microenvironment surrounding the transplanted islets and, thus, enhance islet survival and function...
  25. ncbi Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells
    Vikash Chandra
    National Centre for Cell Science, Ganeshkhind, Pune, India
    Stem Cells 27:1941-53. 2009
    ..p. into streptozotocin-induced diabetic mice, restored normoglycemia within 2 weeks. The data presented here demonstrate the feasibility of using ASCs as a source of autologous stem cells to differentiate into the pancreatic lineage...
  26. ncbi Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation
    Helena Johansson
    The Rudbeck Laboratory, University Hospital, 751 85 Uppsala, Sweden
    Diabetes 54:1755-62. 2005
    ..In conclusion, tissue factor present in both the islets and the culture medium and elicits IBMIR, which affects the function of the transplanted islets...
  27. ncbi Significant role for Fas in the pathogenesis of autoimmune diabetes
    X Su
    Alexion Pharmaceuticals, New Haven, CT 06511, USA
    J Immunol 164:2523-32. 2000
    ..These results provide evidence that Fas/FasL-mediated programmed cell death plays a significant role in the pathogenesis of autoimmune diabetes...
  28. ncbi Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?
    W Bennet
    Department of Transplantation Surgery, Karolinska Institutet, Huddinge Hospital, Sweden
    Diabetes 48:1907-14. 1999
    ....
  29. ncbi Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets
    J Olerud
    Department of Medical Cell Biology, Uppsala University Biomedical Center, Uppsala, Sweden
    Diabetologia 52:2594-601. 2009
    ..Here we investigated whether co-transplantation of neural crest stem cells (NCSCs) with islets improves islet survival and function in normoglycaemic and diabetic mice...
  30. ncbi Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets
    Johan Olerud
    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Diabetes 57:1870-7. 2008
    ..The present study tested the hypothesis that the angiostatic factor thrombospondin-1 (TSP-1), which is normally present in islets, restricts intra-islet vascular expansion posttransplantation...
  31. ncbi Interventional strategies to prevent beta-cell apoptosis in islet transplantation
    Juliet A Emamaullee
    Surgical Medical Research Institute, University of Alberta, Edmonton, AB T6G 2N8
    Diabetes 55:1907-14. 2006
    ..In addition, XIAP has enhanced long-term murine islet allograft survival. The complexities of both intrinsic and extrinsic apoptotic pathway inhibition are discussed in depth...
  32. ncbi Five stages of evolving beta-cell dysfunction during progression to diabetes
    Gordon C Weir
    Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes 53:S16-21. 2004
    ..For type 1 diabetes, as remission develops, progression from stage 4 to stage 2 is typically found. Delineation of these stages provides insight into the pathophysiology of both progression and remission of diabetes...
  33. ncbi Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus
    Garth L Warnock
    Department of Surgery, British Columbia Islet Transplant Centre, University of British Columbia, 950 W 10th Avenue, Vancouver, BC, Canada V5Z 4E3
    Arch Surg 140:735-44. 2005
    ..A local multiorgan donor pancreas procurement program can provide a source for optimized isolation of purified viable islets for transplantation into patients with type 1 diabetes mellitus receiving best medical therapy...
  34. ncbi Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes
    A N Balamurugan
    Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Pancreas 32:231-43. 2006
    ..All together, islet cell transplantation is moving forward...
  35. ncbi Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol
    E A Ryan
    Department of Medicine, Surgical Medical Research Institute, University of Alberta, Edmonton, Canada
    Diabetes 50:710-9. 2001
    ..An elevation of creatinine appears to be a contraindication to this immunosuppressive regimen. For the subjects who had labile type 1 diabetes that was difficult to control, the risk-to-benefit ratio is in favor of islet transplantation...
  36. ncbi Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes
    Khalid Al Ghofaili
    Department of Medicine University of British Columbia, Vancouver, BC
    Transplantation 83:24-8. 2007
    ..We evaluated the effect of exenatide on insulin secretion after islet transplantation...
  37. ncbi Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody
    Bernhard J Hering
    Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota, Minneapolis, MN, USA
    Am J Transplant 4:390-401. 2004
    ..Our preliminary results thus suggest that a combination of maximized viable islet yield, pretransplant islet culture, and preemptive immunosuppression can result in successful single-donor islet transplants...
  38. ncbi Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts
    Neal R Barshes
    Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 6550 Fannin, Suite 1628, Houston, TX 77030, USA
    J Leukoc Biol 77:587-97. 2005
    ....
  39. ncbi Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia
    Montserrat Biarnés
    Laboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, CSUB Hospital de Bellvitge, University of Barcelona, Barcelona, Spain
    Diabetes 51:66-72. 2002
    ..Increased apoptosis and reduced beta-cell mass were also found in islets exposed to chronic hyperglycemia, suggesting that sustained hyperglycemia increased apoptosis in transplanted beta-cells...
  40. ncbi Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver
    Goran Mattsson
    Department of Medical Cell Biology, Biomedical Center, Uppsala University, Uppsala, Sweden
    Diabetes 53:948-54. 2004
    ..The results implicate changes in islet function after intraportal transplantation. Such dysfunction may contribute to the high number of islets needed for successful transplantation in diabetic individuals...
  41. ncbi Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation
    Ulrika Johansson
    Department of Clinical Immunology, The Rudbeck Laboratory, Uppsala University C11, Sweden
    Biochem Biophys Res Commun 308:474-9. 2003
    ..In conclusion, several inflammatory mediators were expressed in isolated islets, particularly at an early stage after isolation, indicating that a few days of culture could be beneficial for the outcome of islet transplantation...
  42. ncbi Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice
    A Casu
    Division of Immunogenetics, Department of Pediatrics, Children s Hospital of Pittsburgh, Rangos Research Centre, Rm 6103, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA
    Diabetologia 51:120-9. 2008
    ..The present study investigated and compared relevant gluco-metabolic parameters in pigs, monkeys and the pig-to-monkey islet transplantation model to gain insight into the potential clinical outcome of pig-to-human islet transplantation...
  43. ncbi The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice
    Juliet A Emamaullee
    Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    Diabetes 57:1556-66. 2008
    ..EP1013 (N-benzyloxycabonyl-Val Asp-fluoromethyl ketone [zVD-FMK]), is a broad-spectrum caspase selective inhibitor with no observed toxicity in rodents...
  44. ncbi Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla
    Joo Ho Tai
    FRCPath, Novartis/Stiller Professor of Xenotransplantation, Robarts Research Institute, Room 200, SDRI Building, University of Western Ontario, 1400 Western Rd, London, Ontario, Canada
    Diabetes 55:2931-8. 2006
    ..These data provide evidence that islets can be labeled with SPIO and imaged using clinically available 1.5- T MRI...
  45. ncbi Islet transplant: an option for childhood diabetes?
    E Hathout
    Division of Endocrinology and Diabetes, Loma Linda University Children s Hospital, Loma Linda, USA
    Arch Dis Child 88:591-4. 2003
    ..The outcomes of these initial investigations are predicted to shape the future boundaries of islet transplantation, diabetes, and transplantation...
  46. ncbi The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report
    Michelle A Fung
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Transplantation 84:17-22. 2007
    ..The effect of islet cell transplantation (ICT) on renal function in type 1 diabetes is uncertain and some recent studies report a significant decline in estimated glomerular filtration rate (GFR) and worsening of albuminuria...
  47. ncbi Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis
    Syed A Ahmad
    Pancreatic Disease Center, Department of Surgery, University of Cincinnati, Cincinnati, OH 45219, USA
    J Am Coll Surg 201:680-7. 2005
    ..01). CONCLUSIONS: The likelihood of glycemic control after IAT is related to both patient characteristics and islet cell mass. Based on these data, more islet cells may be required for insulin independence than previously thought...
  48. ncbi Beneficial role of pancreatic microenvironment for angiogenesis in transplanted pancreatic islets
    Joey Lau
    Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Cell Transplant 18:23-30. 2009
    ....
  49. ncbi Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function
    Takeru Matsuda
    Southern California Islet Cell Resources Center, Department of Diabetes, Endocrinology and Metabolism, City of Hope National Medical Center/Beckman Research Institute, Duarte, CA, USA
    Am J Transplant 5:484-93. 2005
    ..These results suggest that inhibition of the p38 pathway may become a new therapeutic strategy to improve graft survival in clinical islet transplantation...
  50. ncbi Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin
    Young Lee
    Gifford Laboratories of the Touchstone Center for Diabetes Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8854, USA
    Diabetes 56:2295-301. 2007
    ..Graft failure is prevented by blocking lipogenesis. The results suggest that strict antilipogenic intervention might improve outcomes after human islet transplantation...
  51. ncbi Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies
    Rita Bottino
    Division of Immunogenetics, Department of Pediatrics, Children s Hospital of Pittsburgh, Rangos Research Center, Pittsburgh, PA 15213, USA
    Xenotransplantation 14:74-82. 2007
    ..To limit the costs involved in the logistics and health care of pigs for clinical xenotransplantation, we have studied whether younger, rather than older, pigs that are typically preferred can be used as islet donors...
  52. ncbi The portal immunosuppressive storm: relevance to islet transplantation?
    A M James Shapiro
    Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    Ther Drug Monit 27:35-7. 2005
    ..This "portal storm" of immunosuppression may be relevant to intrahepatic islet transplantation...
  53. ncbi Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation
    Robert B Elliott
    Living Cell Technologies, Aukland, New Zealand
    Xenotransplantation 14:157-61. 2007
    ..The long-term viability and function of transplanted encapsulated neonatal porcine islets was examined in a diabetic patient...
  54. ncbi MRI of transplanted pancreatic islets
    Daniel Jirak
    Department of Radiodiagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
    Magn Reson Med 52:1228-33. 2004
    ..This study, therefore, represents a promising step toward possible clinical application in human medicine...
  55. ncbi Oxygenation of islets and its role in transplantation
    Joey Lau
    Department of Medical Cell Biology, Uppsala University, Sweden
    Curr Opin Organ Transplant 14:688-93. 2009
    ..To summarize recent studies on the oxygenation of pancreatic islets and its role in islet transplantation...
  56. ncbi Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets
    Masafumi Goto
    Department of Radiology, Oncology and Clinical Immunology, Division of Clinical Immunology, The Rudbeck Laboratory, Uppsala, Sweden
    Transplantation 77:741-7. 2004
    ....
  57. ncbi Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?
    Per Westermark
    Linkoping University, Department of Biomedicine and Surgery, Cell Biology, 12, University Hospital, Linkoping SE 581 85, Sweden
    Curr Diab Rep 5:184-8. 2005
    ..The possible role of IAPP aggregation and amyloid formation in loss of islet transplant function should be taken into consideration and studied further...
  58. ncbi Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets
    Jyuhn Huarng Juang
    Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung University and Memorial Hospital, Taoyuan, Taiwan
    Cell Transplant 17:641-7. 2008
    ..30 +/- 0.11 vs. 0.13 +/- 0.03 mg, p = 0.012). These results indicate posttransplant exendin-4 treatment in the diabetic recipient with a marginal number of fresh islets expands graft beta-cell mass and improves transplantation outcome...
  59. ncbi GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis
    Kentaro Toyoda
    Department of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto University, 54 Kawahara cho, Shogoin Sakyo ku, Kyoto 606 8507, Japan
    Biochem Biophys Res Commun 367:793-8. 2008
    ..This beneficial effect might be used both to ameliorate type 2 diabetes and to improve engraftment rates in clinical islet transplantation...
  60. ncbi Prolactin supplementation to culture medium improves beta-cell survival
    Toshiyuki Yamamoto
    Cell Transplant Center, Diabetes Research Institute, University of Miami Leonard M Miller School of Medicine, Miami, FL, USA
    Transplantation 89:1328-35. 2010
    ..We examined the effect of human recombinant PRL (rhPRL) supplementation to the culture media to determine its potential use in the context of clinical islet transplantation...
  61. ncbi Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
    Jenny E Gunton
    Joslin Diabetes Center and Harvard Medical School, 1 Joslin Place, Boston, Massachusetts 02215, USA
    Cell 122:337-49. 2005
    ..Together, these data suggest an important role for decreased ARNT and altered gene expression in the impaired islet function of human type 2 diabetes...
  62. ncbi The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation
    Zandong Yang
    Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22908, USA
    Transplantation 77:55-60. 2004
    ..In this study, the authors investigated the potential of LSF in preventing autoimmune diabetes recurrence after islet transplantation...
  63. ncbi Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience
    Tatiana Froud
    Diabetes Research Institute and Departments of Surgery and Radiology, University of Miami, Miami, FL, USA
    Am J Transplant 5:2037-46. 2005
    ....
  64. ncbi Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice
    Denise L Faustman
    Massachusetts General Hospital, Charlestown, MA 02129, USA
    Science 314:1243; author reply 1243. 2006
    ..We show that islet regeneration predominately originates from endogenous cells but that introduced spleen cells can also contribute to islet recovery...
  65. ncbi Enhancing engraftment of islets using perioperative sodium 4-phenylbutyrate
    Brend Ray Sea Hsu
    Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Lin Kou Medical Center, 5 Fu Shin St Kwei Shan County, Tao Yuan Hsien, Taiwan
    Int Immunopharmacol 6:1952-9. 2006
    ....
  66. ncbi Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes
    Seh-Hoon Oh
    Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, 32610, USA
    Lab Invest 84:607-17. 2004
    ..These results demonstrate that adult BM cells are capable of trans-differentiating into a pancreatic lineage in vitro and may represent a pool of cells for the treatment of diabetes mellitus...
  67. ncbi Long-term monitoring of transplanted islets using positron emission tomography
    Yuxin Lu
    Department of Molecular and Medical Pharmacology, University of California at Los Angeles School of Medicine, Los Angeles, CA 90095-1735, USA
    Mol Ther 14:851-6. 2006
    ..These studies suggest that PET imaging of lentivirus-transduced islets could provide a safe and feasible method for long-term monitoring of islet graft survival...
  68. ncbi Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression
    Nicolas Potiron
    , Centre Hospitalo-Universitaire, 30 Boulevard Jean Monnet, 44093 Nantes 01, France
    Cell Transplant 14:263-75. 2005
    ..These results contrast with the efficacy of AdCTLA4Ig we observed in a rat islet allotransplantation model and suggest that islet xenograft rejection might be more difficult to control...
  69. ncbi Rescue purification maximizes the use of human islet preparations for transplantation
    Hirohito Ichii
    Diabetes Research Institute, University of Miami School of Medicine, Miami, Florida, USA
    Am J Transplant 5:21-30. 2005
    ..Taken together, our data suggest that RGP islets are comparable in terms of viability and potency to CGP islets. RGP may be of assistance in maximizing the number of islet preparations successfully used in transplant protocols...
  70. ncbi Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation
    Robert Caiazzo
    INSERM U859, Thérapie Cellulaire du Diabète, Faculte de Medecine, Lille, France
    Transplantation 86:360-3. 2008
    ..85, P<0.01). QIVIPA appears as a reliable test to monitor islet graft potency, applicable to validate new methods to produce primary islets or other human insulin secreting cells...
  71. ncbi Factors influencing functional survival of microencapsulated islet grafts
    Paul De Vos
    Transplantation Biology and Immunoendocrinology, Department of Pathology and Laboratory Medicine, Section of Medical Biology, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
    Cell Transplant 13:515-24. 2004
    ..Our observations indicate that we should focus on reduction of macrophage activation and on improving the nutrition of encapsulated islets to prevent islet cell death...
  72. ncbi Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts
    C A Gysemans
    Laboratory for Experimental Medicine and Endocrinology, Catholic University Leuven, Gasthuisberg, Belgium
    Diabetes 49:1992-7. 2000
    ..These data suggest that early islet xenograft failure is more common in spontaneously diabetic NOD mice and could be due to a nonspecific inflammatory reaction locally in the grafts...
  73. ncbi Development of an ectopic site for islet transplantation, using biodegradable scaffolds
    Jannette M Dufour
    Surgical-Medical Research Institute, University of Alberta, Edmonton, AB, Canada
    Tissue Eng 11:1323-31. 2005
    ..Therefore, islets in scaffolds function and restore diabetic animals to normoglycemic levels, similar to islets transplanted underneath the kidney capsule, suggesting scaffolds can be used to create a site for islet transplantation...
  74. ncbi Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse
    Sulaiman A Nanji
    Roberts Centre, 2000 College Plaza, University of Alberta, 2000 College Plaza, 8215 112 St, Edmonton, Alberta, Canada T6G 2C8
    Diabetes 55:27-33. 2006
    ..These data demonstrate that the blockade of CD40 ligand and ICOS signaling induces islet allograft tolerance involving a dominant mechanism associated with intragraft regulatory cells and prevents autoimmune diabetes in NOD mice...
  75. ncbi Caspase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves islet graft function
    Masahiko Nakano
    Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Pancreas 29:104-9. 2004
    ..CONCLUSION: Z-DEVD-FMK prevented apoptosis of isolated human islets and improved its function. FBS (10%) improved the islet yield and insulin secretion more than 0.5% HSA...
  76. ncbi Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo
    Gunter Path
    Division of Endocrinology and Diabetology, Dept of Internal Medicine II, University Hospital of Freiburg, 79106 Freiburg, Germany
    Am J Physiol Endocrinol Metab 291:E1168-76. 2006
    ..These results establish p8 as a novel molecular mediator of glucose-induced pancreatic beta-cell expansion in vitro and in vivo and support the notion of existing beta-cell replication in the adult organism...
  77. ncbi Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody
    Michael C Appel
    Department of Medicine, Division of Diabetes, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Transplantation 77:1341-9. 2004
    ....
  78. ncbi Preservation of human pancreatic islet in vivo function after 6-month culture in serum-free media
    Benjamin T Rush
    Department of Surgery, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA
    Transplantation 77:1147-54. 2004
    ..The ability to maintain islets in culture for prolonged periods is an important step toward the development of islet tissue repositories and distribution centers...
  79. ncbi Porcine islet graft function is affected by pretreatment with a caspase-3 inhibitor
    Daniel Brandhorst
    Department of Clinical Immunology, Rudbeck Laboratory, Uppsala University Hospital, 75185 Uppsala, Sweden
    Cell Transplant 15:311-7. 2006
    ..05). The study demonstrates that short-time pretreatment with the caspase-3 inhibitor DEVD-CMK reduces the capacity of transplanted porcine islets to restore normoglycemia in diabetic nude mice...
  80. ncbi Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice
    Tsunehiro Kobayashi
    First Department of Surgery, Nara Medical University, Nara, 634 8522, Japan
    Cell Transplant 15:359-65. 2006
    ..These results demonstrate the long-term durability of agarose microcapsules against autoimmunity in a syngeneic islet transplantation model in NOD mice...
  81. ncbi Effect of glucose toxicity on intraportal tilapia islet xenotransplantation in nude mice
    Ayman Al-Jazaeri
    Department of Pathology, IWK Health Centre, Halifax, Nova Scotia, B3H 1V7, Canada
    Xenotransplantation 12:189-96. 2005
    ..CONCLUSIONS: Our results suggest that ''glucose toxicity'' plays a role in the immediate demise of intraportal tilapia islet xenografts...
  82. ncbi Reversal of established autoimmune diabetes by restoration of endogenous beta cell function
    S Ryu
    Immunobiology Laboratory, Harvard Medical School and Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
    J Clin Invest 108:63-72. 2001
    ..A therapy aimed at the selective elimination of autoreactive cells and the reeducation of T cells, when combined with control of glycemia, is thus able to effect an apparent cure of established type 1 diabetes in the NOD mouse...
  83. ncbi Secretory unit of islet in transplantation (SUIT) and engrafted islet rate (EIR) indexes are useful for evaluating single islet transplantation
    Hirofumi Noguchi
    Transplantation Unit, Kyoto University Hospital, Kyoto 606 8507, Japan
    Cell Transplant 17:121-8. 2008
    ..The SUIT and EIR indexes are thus considered to be useful values for evaluating islet transplantation, especially for single islet transplantation...
  84. ncbi Beneficial effects of hyperbaric oxygen therapy on islet transplantation
    Jyuhn Huarng Juang
    Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
    Cell Transplant 11:95-101. 2002
    ....
  85. ncbi Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes
    Tatiana D Zorina
    Department of Pediatrics, University of Pittsburgh, School of Medicine, PA 15213, USA
    Cell Transplant 11:113-23. 2002
    ..Also, we have demonstrated that, in the NOD model, recipient conditioning resulting in as low as 1% of chimerism is sufficient to promote engraftment of the BM donor-specific islets of Langerhans...
  86. ncbi Genetically modified adenovirus vector containing an RGD peptide in the HI loop of the fiber knob improves gene transfer to nonhuman primate isolated pancreatic islets
    Guadalupe Bilbao
    Department of Medicine, University of Alabama at Birmingham 35294, USA
    Am J Transplant 2:237-43. 2002
    ..Incorporation of the RGD sequence in the HI loop of the fiber knob allows highly efficient transfection efficiency to nonhuman primate insulin-producing cells and adequate long-term function of the p-cell after transplantation...
  87. ncbi Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss
    R Neal Smith
    Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
    Transplantation 86:54-62. 2008
    ..After each islet transplant, she gradually lost insulin independence while maintaining low levels of C-peptide secretion...
  88. ncbi Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site
    Boaz Hirshberg
    National Institute of Diabetes and Digestive and Kidney Diseases Navy Transplantation and Autoimmunity Branch, NIH, Building 10 Rm 11S219, 10 Center Drive, Bethesda, MD 10889, USA
    Diabetes 51:2135-40. 2002
    ..Arterial islet injection, however, does not appear to be a viable islet transplantation technique...
  89. ncbi Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients
    S Prange
    Department of Microbiology and Immunology, University of Western Ontario, London Health Sciences Centre and the John P. Robarts Research Institute, Canada
    Transplantation 71:982-5. 2001
    ..These studies demonstrate the primary role of MHC class I molecules in causing autoimmune destruction or recurrent diabetes in transplanted islets...
  90. ncbi Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720
    Fumin Fu
    Novartis Institute for Biomedical Research, Summit, New Jersey; Novartis Pharma AG, Basel, Switzerland
    Transplantation 73:1425-30. 2002
    ..The effect is likely attributable to its action in preventing effector lymphocyte infiltration into the grafted tissue...
  91. ncbi Isolation, transplantation, and functional studies of adult porcine islets of Langerhans
    Thomas Buschmann Nielsen
    Department of Medical Endocrinology/Biomedical Laboratory, Odense University Hospital, Denmark
    Comp Med 52:127-35. 2002
    ..In conclusion, it is possible to isolate viable islets from adult pigs, using a semiautomatic set-up. With batch-to-batch variation, the islets are able to revert diabetes mellitus when transplanted to diabetic nude mice...
  92. ncbi Cryopreservation and xenotransplantation studies of microencapsulated rat pancreatic islets
    Bao-guo Li
    Institute of Cryobiological Engineering, Shanghai University of Science and Technology, No.516 Jun Gong Road, Shanghai, 200093, China
    Cryo Letters 23:47-54. 2002
    ..They only reversed hyperglycemia for less than 3-5 days...
  93. ncbi Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes
    Angela M Alexander
    Division of Immunogenetics, Department of Pediatrics, Rangos Research Center, Children's Hospital of Pittsburgh, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Diabetes 51:356-65. 2002
    ..These results suggest that local modulation of tryptophan catabolism may be a means of facilitating islet transplantation as a therapy for type 1 diabetes...
  94. ncbi Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes
    Jon G Mabley
    Inotek Pharmaceuticals Corp, Beverly, MA 01915, USA
    Mol Med 9:96-104. 2003
    ..The use of inosine should be considered as a potential preventative therapy in humans susceptible to developing Type 1 diabetes and as a possible antirejection therapy for islet transplant recipients...
  95. ncbi Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice
    Wilma L Suarez-Pinzon
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Cell Transplant 17:631-40. 2008
    ....
  96. ncbi Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene
    J L Contreras
    Transplant Immunobiology Division, Transplant Center, University of Alabama at Birmingham, USA
    Transplantation 71:1015-23. 2001
    ....
  97. ncbi C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets
    K Tatarkiewicz
    Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Diabetologia 44:646-53. 2001
    ..However, this delay in reaching peripheral target organs does not prevent microencapsulated grafts from efficiently clearing glucose after a meal...
  98. ncbi Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days
    L Wennberg
    Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden
    Transplantation 71:1024-33. 2001
    ..CONCLUSIONS: Well-functioning APIs can be isolated in large numbers. API xenografts can be protected from rejection and can maintain an adequate function for up to 100 days, in rats immunosuppressed with CsA+MMF+LEF...
  99. ncbi Reestablishment of microenvironment is necessary to maintain in vitro and in vivo human islet function
    Nalu Navarro-Alvarez
    Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700 8558, Japan
    Cell Transplant 17:111-9. 2008
    ..These studies indicate that the reestablishment of the cell-matrix interactions by a synthetic matrix in the immediate postisolation period is a useful tool to maintain islet functions in vitro and in vivo...
  100. ncbi Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation
    Y Clare Zhang
    Department of Pathology, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610, USA
    Transplantation 74:1184-6. 2002
    ..Islet expression of IL-4 led to impaired metabolic function in mice receiving a marginal mass of syngeneic islets...

Research Grants86

  1. PANCREAS AND ISLET TRANSPLANTATION IN HUMANS
    R Robertson; Fiscal Year: 2005
    ..Studies of the mechanism of glucagon release during hypoglycemia and its disappearance in the absence of beta cells will be conducted in Sprague Dawley rats. ..
  2. Spleen regulation of beta-cell regeneration
    Anita Chong; Fiscal Year: 2007
    ..We will also test whether expression of the ligands of LT¿R, LTa¿ or LIGHT, on spleen cells and LT¿R on islet ¿-cells is critical for stimulating ¿-cell regeneration. ..
  3. Inflammation and T Cell Memory: Inter-related Barriers to Allograft Tolerance
    Terry Strom; Fiscal Year: 2007
    ..Detailed mechanistic studies will be performed and the analyses planned should provide clinically relevant information for rationally developing new tolerance strategies for not only kidney but also all allograft recipients. ..
  4. Pig to Non-Human Primate Islet Xenografts
    Judith Thomas; Fiscal Year: 2007
    ..These studies are unique and will generate new data on pig-to-NHP XPITx immunobiology and the immune mechanisms influencing development of pig XPITx tolerance. ..
  5. Donor CD8+ cell facilitates mixed chimerism in NOD mice
    Defu Zeng; Fiscal Year: 2005
    ..abstract_text> ..
  6. Improved recombinant collagenase for tissue dissociation
    Robert McCarthy; Fiscal Year: 2007
    ....
  7. IMPACT OF STANDARDIZATION AND PROCEDURE OPTIMIZATION ON*
    Ahmed Gaber; Fiscal Year: 2005
    ..This team has worked well together with the aim of curing diabetes through islet transplantation. ..
  8. Donation After Cardiac Death for Isolated Pancreatic Is*
    Luis Fernandez; Fiscal Year: 2006
    ..In addition, the development of rapid, accurate, and predictive tests of islet viability and function post isolation will contribute to significant improvements in post transplant success. ..
  9. PANCREAS AND ISLET TRANSPLANTATION IN HUMANS
    R Robertson; Fiscal Year: 2001
    ....
  10. Growth Factor and Antiapoptotic Gene Delivery to Human Islets
    Ram I Mahato; Fiscal Year: 2010
    ..This will decrease the number of islets required to achieve normoglycemia in type I diabetic patients. ..
  11. Growth Factor and Antiapoptotic Gene Delivery to Human Islets
    RAM MAHATO; Fiscal Year: 2009
    ..This will decrease the number of islets required to achieve normoglycemia in type I diabetic patients. ..
  12. Parathyroid Hormone-Related Protein and the Pancreatic Beta Cell
    Rupangi Vasavada; Fiscal Year: 2009
    ....
  13. Parathyroid Hormone-Related Protein and the Pancreatic Beta Cell
    Rupangi C Vasavada; Fiscal Year: 2010
    ....
  14. Parathyroid Hormone-Related Protein and the Pancreatic Beta Cell
    Rupangi C Vasavada; Fiscal Year: 2010
    ....
  15. ISLET-KIDNEY TRANSPLANTS FOR TREATMENT OF DIABETIC ESRD
    David Sachs; Fiscal Year: 2006
    ..We anticipate that the use of pre-vascularized islets as part of a composite islet-kidney transplant may provide a new and effective treatment modality for patients with class I diabetes and end-stage renal disease. ..
  16. Treg suppression of islet allograft rejection
    Zhenhua Dai; Fiscal Year: 2010
    ....
  17. REVERSAL OF DIABETES BY ISLET TRANSPLANTATION
    Ronald Gill; Fiscal Year: 1993
    ..The grafting of islet tissue from a number of different allogeneic strains to spontaneously diabetic BB rats will be used to define and investigate this problem in greater depth...
  18. B Cell immunomodulation in islet transplantation
    Ali Naji; Fiscal Year: 2006
    ..Our overall contention is that interruption of T- and B- lymphocyte function during the induction phase represents a novel and potentially powerful means of promoting immunological tolerance to islet allografts. ..
  19. PANCREAS AND ISLET TRANSPLANTATION IN HUMANS
    R Robertson; Fiscal Year: 2009
    ....
  20. PANCREAS AND ISLET TRANSPLANTATION IN HUMANS
    R Robertson; Fiscal Year: 2007
    ....
  21. B-Lymphocyte Immunotherapy in Islet Transplantation
    Ali Naji; Fiscal Year: 2007
    ..abstract_text> ..
  22. A new approach to xenotransplantation in primate
    Juan Contreras; Fiscal Year: 2005
    ..The research proposed in this grant will provide significant information to the xenotransplant research and the potential use of porcine islets as an alternative to human tissue for pancreatic islet transplantation. ..
  23. Anti-inflammatory Serpin(AAT and Elafin) Gene Transfers*
    Sihong Song; Fiscal Year: 2003
    ..abstract_text> ..
  24. Gene transfer with A20 to improve islet transplantation
    Christiane Ferran; Fiscal Year: 2003
    ..This will overcome the requirement for high numbers of islets and the need for intensive immunosuppression. Beneficial results would pave the way for pre-clinical (primates) and clinical applications. ..
  25. Commercial Feasibility Assessment of Pancreatic Islet Progenitor Cell Technology
    Kelvin Brockbank; Fiscal Year: 2007
    ....
  26. Molecularly Engineered Blockade of Islet Induced Inflammatory Responses
    Elliot Chaikof; Fiscal Year: 2010
    ....
  27. Novel SOD-mimetics for type 1 diabetes
    ELWOOD REYNOLDS; Fiscal Year: 2006
    ..The commercial goal is to develop an orally active drug which can prevent or delay onset of T1D, and/or improve the transplantation process by reducing the toxicity of immunosuppression and by increasing donor islet yield. ..
  28. Tissue Dissociation Enzymes for Islets & Other Cells
    Robert McCarthy; Fiscal Year: 2005
    ..This knowledge offers the potential to use fewer, more effective enzymes in TDE mixtures, leading to increases in the yield and quality of cells recovered from any mammalian organ. ..